Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | GILD | CELG | BIIB |
| Company | Celldex Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 41.91 | 313.39 | 65.51 | 108.01 | 215.30 |
| High | 42.98 | 322.60 | 65.53 | 108.59 | 217.88 |
| Low | 41.34 | 308.68 | 64.33 | 107.27 | 213.11 |
| Last | 42.56 | 311.29 | 64.78 | 108.24 | 217.51 |
| Change | +1.70 | +32.90 | -0.55 | +0.11 | +4.00 |
| % Change | +4.16% | +11.82% | -0.84% | +0.10% | +1.87% |
| Volume | 605,300 | 9,644,601 | 7,822,700 | 191,230,496 | 1,144,100 |
| 20-Day Average Volume | 587,645 | 2,646,885 | 7,406,455 | 16,188,930 | 1,344,250 |
| Previous Close | 40.86 | 278.39 | 65.33 | 108.13 | 213.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.84 | 272.27 | 66.88 | 108.17 | 203.10 |
| 20-Day Raw Stochastic | 94.27% | 81.73% | 8.01% | 63.25% | 95.41% |
| 20-Day Relative Strength | 57.25% | 72.10% | 30.11% | 64.69% | 56.41% |
| Weighted Alpha | +14.60 | +33.76 | -22.64 | +46.30 | -29.51 |
| Today's Opinion | 72% Buy | 24% Buy | 100% Sell | 100% Buy | 56% Sell |
| Previous Opinion | 48% Buy | 16% Sell | 100% Sell | 100% Buy | 56% Sell |
| Last Month's Opinion | 56% Buy | 24% Sell | 100% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.25% since 04/26/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 | -1.97% since 11/13/19 | +4.12% since 04/26/24 |
| Low | 36.35 on 04/30/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 208.54 on 04/29/24 |
| High | 42.98 on 05/03/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 | 110.53 on 11/14/19 | 218.86 on 04/29/24 |
| 1-Month | |||||
| %Chg | +5.48% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 | +5.14% since 10/18/19 | +5.39% since 04/03/24 |
| Low | 35.65 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 42.98 on 05/03/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 | 110.70 on 11/13/19 | 218.86 on 04/29/24 |
| 3-Month | |||||
| %Chg | +19.75% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 | +13.63% since 08/20/19 | -10.75% since 02/02/24 |
| Low | 35.03 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 | 110.70 on 11/13/19 | 246.44 on 02/07/24 |
| 6-Month | |||||
| %Chg | +63.82% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 | +14.14% since 05/20/19 | -12.82% since 11/03/23 |
| Low | 25.08 on 11/09/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,284,115 | 149,321,728 | 81,340,888 | 77,035,920 | 31,086,416 |
| Shares Outstanding, K | 55,901 | 536,376 | 1,245,077 | 711,714 | 145,597 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 4,130,000 | 8,196,000,000 | 6,686,000,000 | 4,520,000,000 | 2,290,500,000 |
| Last Quarter Net Income | -43,310,000 | 767,000,000 | -4,170,000,000 | 1,691,000,000 | 393,400,000 |
| 60-Month Beta | 1.60 | 0.60 | 0.22 | 1.41 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 16.26 | 10.99 | 14.41 |